Cancer Research Antibodies

We offer thousands of primary antibodies for use in cancer research. Whether you’re research is focused on metastasis, proliferative signaling, apoptosis, autophagy, metabolism, inflammation, tumor suppressors or any other cancer-related research area, we have a broad selection of research antibodies to help ensure your success. Use our antibody search tool below to find the right Invitrogen™ antibody for your research.

Already know your cancer research target of interest?

Find antibodies of interest using the search tool below. Then filter the results by target or host species, monoclonal or polyclonal antibody type, and other criteria.

Featured cancer research antibody categories

There are at least three distinct mitogen-activated protein kinase (MAPK) signaling modules which mediate extracellular signals into the nucleus to turn on the responsive genes in mammalian cells, including ERK, JNK, and p38 kinase. The MAPK signaling pathway is essential in regulating many cellular processes including inflammation, cell differentiation, cell proliferation and death. Use antibodies to study the role of MAPK pathway in cancer, immune disorders and neurodegenerative diseases.

The serine–threonine kinase Akt (also known as protein kinase B) is a central convergence node in a broadly influential signaling network. Akt activation serves as a master switch of these cellular signaling pathways, generating a multitude of intracellular responses through a plethora of downstream targets and interacting partners. Use antibodies to examine key targets including AKT1, AKT2, AKT3, and PI3K.

We offer affinity-purified rabbit polyclonal or monoclonal antibodies that are monospecific for a target protein that is phosphorylated on a specific tyrosine, threonine, or serine residue. Our phosphospecific antibodies can be used in a wide variety of immunodetection applications including immunohistochemistry, quantitative ELISA and flow cytometry. Key targets include SRC, FAK, Tau, EIF2, AKT, ERK, JAK, STAT, and MAPK.

We offer a wide selection of specific primary antibodies for studying transcription factors that have been validated for multiple applications, such as western blotting, immunfluorescence, ELISA, and immunohistochemistry. Key targets include CREB, E2F-1, c-Myc, c-Fos, AP2, AID, CDX2, ETS1, E2F-1, and 4EBP1.

GTP hydrolases (GTPases) are capable of binding and cleaving GTP. The GTPase family contains sub families such as the RAS super family which is critical to cell signaling. We offer high-quality antibodies against a number of GTPase targets for use in applications including western blotting, immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry (IHC), and ELISA. Key targets include RAC, RAS, ARF, RHO, RAB, and Cdc42.

Related application and cell analysis categories

Analyze how cell signaling pathways are disrupted in cancer by accurately quantifying intracellular and extracellular proteins using protein analysis tools designed for single or multiplex cancer biomarker analysis.

Evaluate the hallmarks of cancer with our many cell analysis assays, which have been validated on multiple instrument platforms and applications: microscopy, flow cytometry, microplate readers, and high-content screening.